secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health In Tech, Inc. (HIT)
CIK:        0002019505
Form:       8-K
Filed at:   2025-03-17T23:59:59+00:00
Accession:  0001213900-25-024575
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health In Tech FY2024 revenue $19.5M (+1.8%); adj. EBITDA falls to $2.3M from $4.8M; leadership reshuffled
--------------------------------------------------------------------------------

- Full-year 2024 revenue $19.5M (+1.8% YoY); income from continuing ops $0.7M vs $2.5M in 2023.
- Q4 2024 revenue $4.9M vs $5.2M; net loss from continuing ops ($0.1M) vs income $1.0M; adjusted EBITDA $0.5M vs $1.0M.
- Cash $7.8M at Dec 31, 2024 (up from $2.4M); total liabilities $2.6M (down from $5.4M).
- Unaudited Jan-Feb 2025 revenue ~$5.7M, >50% YoY growth, exceeding entire Q1 2024.
- Leadership changes: Chris Kurtenbach promoted to COO; Dustin Plantholt named Chief Growth Officer; Jenni Guerrica CISO; Jonathan Del Lockett becomes Chief Strategy Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2019505/000121390025024575/0001213900-25-024575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2019505/000121390025024575/ea0234672-8k_health.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-024575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer